Peer reviewed Feature Articles
Respiratory infections

Respiratory syncytial virus infection: what’s available to prevent it and what’s coming?

Luke Spence, Mark R. Armstrong, Paul M. Griffin

Respiratory syncytial virus infection prevention is advancing with long-acting monoclonal antibodies and new vaccines approved for older adults and pregnant women. Targeted public health initiatives, standardised national policies and community engagement will be key to ensure these preventives reach all populations.

September 2024
More
Peer reviewed Feature Articles
 

Physician-authored summaries and commentary on the most important medical research, provided by the NEJM Group, a division of the Massachusetts Medical Society.

© Massachusetts Medical Society
How do asthma biologics stack up? Ann Am Thorac Soc
Pneumonia is misdiagnosed often in hospitalised patients JAMA Intern Med
Real-world data on nirsevimab to prevent RSV bronchiolitis in infants N Engl J Med
Hospitalisation as an opportunity to improve inhaler technique Swiss Med Wkly
Healthy children shed respiratory viruses for a long time J Pediatr Infect Dis Soc
Is influenza a risk factor for subsequent acute myocardial infarction? NEJM Evid
Can early detection and treatment of patients with COPD or asthma improve outcomes? N Engl J Med